{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:11:46Z","timestamp":1765609906247,"version":"3.37.3"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T00:00:00Z","timestamp":1552435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0213524","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T17:40:22Z","timestamp":1552498822000},"page":"e0213524","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Treatment of latent Mycobacterium tuberculosis infection with 12 once weekly directly-observed doses of isoniazid and rifapentine among persons experiencing homelessness"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6695-3387","authenticated-orcid":true,"given":"Nwabunie","family":"Nwana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne M.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0963-2501","authenticated-orcid":true,"given":"Edward","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia H.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Holcombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2493-1411","authenticated-orcid":true,"given":"Sapna Bamrah","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,3,13]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"e0153728","DOI":"10.1371\/journal.pone.0153728","article-title":"Recent Transmission of Tuberculosis\u2014United States, 2011\u20132014","volume":"11","author":"CM Yuen","year":"2016","journal-title":"PLoS One"},{"year":"2017","key":"ref2","article-title":"Reported tuberculosis in the United States, 2016"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2016.11046","article-title":"Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement","volume":"316","author":"K Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.5588\/ijtld.13.0270","article-title":"Tuberculosis among the homeless, United States, 1994\u20132010","volume":"17","author":"S Bamrah","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"issue":"22","key":"ref5","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1001\/jama.293.22.2762","article-title":"Tuberculosis and homelessness in the united states, 1994\u20132003","volume":"293","author":"MB Haddad","year":"2005","journal-title":"JAMA"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.15585\/mmwr.mm6611a2","article-title":"Tuberculosis\u2014United States, 2016","volume":"66","author":"KM Schmit","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"22","key":"ref7","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium tuberculosis infection","volume":"372","author":"H Getahun","year":"2015","journal-title":"N Engl J Med"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.5588\/ijtld.10.0650","article-title":"Predictors of discordant tuberculin skin test and QuantiFERON(R)-TB Gold In-Tube results in various high-risk groups","volume":"15","author":"P Weinfurter","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"e0140881","DOI":"10.1371\/journal.pone.0140881","article-title":"Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011\u20132012","volume":"10","author":"R Miramontes","year":"2015","journal-title":"PLOS ONE"},{"issue":"Rr-6","key":"ref10","first-page":"1","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"49","year":"2000","journal-title":"American Thoracic Society. MMWR Recomm Rep"},{"issue":"7","key":"ref11","first-page":"775","article-title":"A randomized controlled trial of two treatment programs for homeless adults with latent tuberculosis infection","volume":"10","author":"AM Nyamathi","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-149-10-200811180-00003","article-title":"Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: a randomized trial","volume":"149","author":"D Menzies","year":"2008","journal-title":"Ann Intern Med"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5588\/ijtld.14.0373","article-title":"Latent tuberculous infection in the United States and Canada: who completes treatment and why?","volume":"19","author":"Y Hirsch-Moverman","year":"2015","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw082","article-title":"Predictors of Latent Tuberculosis Infection Treatment After Introduction of a New Regimen: A Retrospective Cohort Study at an Inner City Clinic","volume":"3","author":"A Yamin","year":"2016","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1164\/rccm.200303-390OC","article-title":"Use of isoniazid for latent tuberculosis infection in a public health clinic","volume":"168","author":"PA LoBue","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"ref16","first-page":"847","article-title":"How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?","volume":"3","author":"GW Comstock","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"issue":"48","key":"ref17","first-page":"1650","article-title":"Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection","volume":"365","author":"TR Sterling","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"ref19","article-title":"High Rate of Treatment Completion in Program Settings with 12-Dose Weekly Isoniazid and Rifapentine (3HP) for Latent Mycobacterium tuberculosis Infection","author":"AL Sandul","year":"2017","journal-title":"Clin Infect Dis"},{"key":"ref20","unstructured":"U.S. Department of Housing and Urban Development (HUD). Homeless Emergency Assistance and Rapid Transition to Housing Act of 2009 (P.L. 111\u201322, Section 1003)]. 2009."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12879-016-1550-y","article-title":"Initiation and completion rates for latent tuberculosis infection treatment: a systematic review","volume":"16","author":"A Sandgren","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12879-017-2377-x","article-title":"Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses","volume":"17","author":"C Pease","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"11","key":"ref23","first-page":"1235","article-title":"Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada","volume":"12","author":"Y Hirsch-Moverman","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12879-016-1549-4","article-title":"Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review","volume":"16","author":"AL Stuurman","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"9","key":"ref25","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.5588\/ijtld.14.0829","article-title":"Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI","volume":"19","author":"EE Bliven-Sizemore","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"286","DOI":"10.5588\/ijtld.16.0469","article-title":"Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial","volume":"21","author":"RN Moro","year":"2017","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1037\/0278-6133.26.1.68","article-title":"Latent variable assessment of outcomes in a nurse-managed intervention to increase latent tuberculosis treatment completion in homeless adults","volume":"26","author":"A Nyamathi","year":"2007","journal-title":"Health Psychol"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2105\/AJPH.90.3.435","article-title":"Hospitalization of homeless persons with tuberculosis in the United States","volume":"90","author":"SM Marks","year":"2000","journal-title":"American Journal of Public Health"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.cct.2006.09.003","article-title":"Factors associated with loss to follow-up in a large tuberculosis treatment trial (TBTC Study 22)","volume":"28","author":"DS Conwell","year":"2007","journal-title":"Contemp Clin Trials"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/cid\/ciw126","article-title":"Factors Associated With Noncompletion of Latent Tuberculosis Infection Treatment: Experience From the PREVENT TB Trial in the United States and Canada","volume":"62","author":"RN Moro","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"8","key":"ref31","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0002-9343(01)00695-7","article-title":"A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users","volume":"110","author":"RE Chaisson","year":"2001","journal-title":"The American Journal of Medicine"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1164\/ajrccm\/146.1.57","article-title":"Results of a directly observed intermittent isoniazid preventive therapy program in a shelter for homeless men","volume":"146","author":"V Nazar-Stewart","year":"1992","journal-title":"Am Rev Respir Dis"},{"issue":"25","key":"ref33","doi-asserted-by":"crossref","first-page":"723","DOI":"10.15585\/mmwr.mm6725a5","article-title":"Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection","volume":"67","author":"AS Borisov","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"ref34","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/M17-1150","article-title":"Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial","volume":"167","author":"R Belknap","year":"2017","journal-title":"Ann Intern Med"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5588\/ijtld.14.0052","article-title":"Update on cost-effectiveness of a 12-dose regimen for latent tuberculous infection at new rifapentine prices","volume":"18","author":"D Shepardson","year":"2014","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0213524","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T04:29:27Z","timestamp":1588998567000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0213524"}},"subtitle":[],"editor":[{"given":"Katalin Andrea","family":"Wilkinson","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,3,13]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0213524","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2019,3,13]]}}}